Pacira Pharmaceuticals (PCRX) PT Raised to $68 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Oren Livnat raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $68.00 (from $63.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
